Ruben Dalfovo

Join Ruben Dalfovo, Saxo Equity Strategist, as he delves into the unsettling drop in AI stocks, despite Micron's impressive earnings forecast. He shares insights on Tesla's competitive landscape and Oracle's struggle with its costly data-center investments. Dalfovo also analyzes the shifting trends in European fashion, highlighting the disparities between luxury brands and their mid-tier counterparts. Lastly, he looks ahead to the upcoming Bank of Japan meeting and its potential impact on currency and market volatility.

Ruben Dalfovo, equity strategist focused on tech, AI and earnings, breaks down major company reports. He discusses Microsoft’s AI spending and market shock, Meta’s monetization path, Tesla’s AI pivot and transparency concerns, and previews Apple, Amazon and Alphabet prints. He also reviews how the Kevin Warsh Fed chatter moved yields, commodities and FX.

Ruben Dalfovo, an equity strategist at Saxo, shares his insights on the recent shakeup in the US equity market, spurred by Amazon's impressive earnings. The conversation dives into the mysterious 'Hindenburg Omen' and its mixed track record. Dalfovo analyzes major tech earnings from Meta, Alphabet, and Apple, highlighting contrasts in AI investments and consumer behavior. Key themes include NVIDIA's partnerships and Eli Lilly's strong performance in obesity drugs, leaving listeners curious about next week's pivotal earnings reports.

Ruben Dalfovo, an Equity Strategist at Saxo, delves into the recent turmoil in US equity markets, especially the plummet of AI and crypto-related stocks. He discusses notable companies like Oracle and Disney, highlighting skepticism around Oracle's AI backlog transforming into revenue. The conversation turns to the pivotal Nvidia earnings report and its implications for the market. They also touch on resilient defensive stocks, Bitcoin's liquidity issues, and the dollar's struggle as a safe haven in today's unpredictable landscape.

Ruben Dalfovo, Saxo Equity Strategist who analyzes earnings and AI infrastructure trends. He walks through how the Strait of Hormuz disruption could ripple through markets. Quick takes on Broadcom, CrowdStrike, Marvell and Oracle earnings. Also touches on defense re-rating, obesity drug trial fallout and US-China supply chain tensions.